BRAIN Graphic
Reasons to invest

Reason No. 6: We are active in markets with high barriers to entry

Our novel products & solutions are based on:

  • our proprietary BioArchive
  • an extensive patent portfolio, around 140 patents granted and around 60 patent families
  • a broad and in-depth technology know-how in enzymes, microorganisms and bioactive natural compounds
  • full process capabilities from the lab to production
  • strong industry partner network with over 100 partner collaborations successfully completed
  • strategic alliances for new business development
  • trade secrets
  • strong scientific and university network
  • state-of-the-art technology portfolio
  • our people: first class scientists and process specialists

Share this page